Identification of Blood Pressure‐Associated Metabolites by Integrating Metabolomic and Genetic Analysis
MedComm · 2026-04 · 7 (4)
DOI: 10.1002/mco2.70718 ↗Kurz gefasst
Fachartikel in der Zeitschrift MedComm, online erschienen am 01.04.2026. Verfasst von Yuanjiao Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Disease Sir Run Run Shaw Hospital and Department of Epidemiology and Biostatistics Zhejiang University School of Medicine H…. Die Arbeit nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
This study aimed to identify blood pressure‐associated metabolites and explore their underlying pathways using multiomics data from 1188 Chinese participants. Serum metabolite levels were profiled using untargeted and widely targeted metabolomic technologies. The associations of metabolites as well as ratios with blood pressure were assessed using generalized linear models (GLM). Targeted metabolomics was used to replicate a subset of metabolites. Genome‐wide association studies (GWAS) were performed on all metabolites identified. Potential causality was examined using two‐sample Mendelian randomization (MR) analyses, with partial validation against GWAS results from an independent cohort. This study identified 10 blood pressure‐associated metabolites supported by GLM and MR analyses. Cortisol demonstrated the strongest association with blood pressure, with l ‐glutamic acid and its ratios identified as key drivers. Multiomics integration revealed that a genetic variant near the omega‐3 metabolism genes ( FADS1 / FADS2 ) may influence blood pressure regulation by modulating prostaglandin E3 levels. Mediation analysis indicated that l ‐glutamic acid statistically mediated 12.16–31.53% of the effect of lifestyle factors on blood pressure. These findings enhance our understanding of metabolic mechanisms underlying hypertension and highlight potential biomarkers and therapeutic targets for further investigation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Respiratory Disease Sir Run Run Shaw Hospital and Department of Epidemiology and Biostatistics Zhejiang University School of Medicine Hangzhou Zhejiang China.
- The Second Affiliated Hospital and School of Public Health Zhejiang University School of Medicine Hangzhou China.
- The Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province Hangzhou Zhejiang China.
- Section of Epidemiology and Population Health & Department of Gynecology and Obstetrics Ministry of Education Key Laboratory of Birth Defects and Related Diseases of Women and Children & Children's Medicine Key Laborato…
- West China Biomedical Big Data Center West China Hospital Sichuan University Chengdu China.
- Shuangliu Institute of Women's and Children's Health Shuangliu Maternal and Child Health Hospital Chengdu China.
ORCID-Profile: Yimin Zhu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Liu, Y., Cheng, C., Pan, X. F., Shao, W., Zhou, D., & Zhu, Y. (2026). Identification of Blood Pressure‐Associated Metabolites by Integrating Metabolomic and Genetic Analysis. MedComm, 7(4). https://doi.org/10.1002/mco2.70718
Vancouver
Liu Y, Cheng C, Pan XF, Shao W, Zhou D, Zhu Y. Identification of Blood Pressure‐Associated Metabolites by Integrating Metabolomic and Genetic Analysis. MedComm. 2026;7(4). doi:10.1002/mco2.70718
BibTeX
@article{Liu2026,
author = {Liu, Yuanjiao and Cheng, Chunxiao and Pan, Xiong-Fei and Shao, Wei and Zhou, Dan and Zhu, Yimin},
title = {Identification of Blood Pressure‐Associated Metabolites by Integrating Metabolomic and Genetic Analysis},
journal = {MedComm},
year = {2026},
volume = {7},
number = {4},
doi = {10.1002/mco2.70718}
}
EUVIMED